| Open Document File Size: 373,26 KBShare Result on Facebook
Company OTC Drug Review / The Advisory Review / / Country United States / United Kingdom / / Event Product Issues / FDA Phase / / IndustryTerm to aerosol products / rubber bulb nebulizer / drug product / allergy products / manufacturing practices / prescription drug product / hand-held rubber bulb nebulizers / bronchodilator products / 1percent aqueous solution / pharmaceuticals / hand-held rubber bulb nebulizer / handheld rubber bulb nebulizer / manufacturing expectations / over-the-counter bronchodilator drug products / bronchodilator drug products / inhalation products / drug products / propellant devices / / MedicalCondition heart disease / epidemic proportions / paradoxical bronchoconstriction / intermittent asthma / wheezing / asthma / simple asthma / severe paradoxical bronchoconstriction / bronchial asthma / shortness of breath / available Asthma / serious asthma / Allergy / cardiac disease / high blood pressure / Cough / severe asthma / / Organization Food and Drug Administration / FDA Briefing Document Nonprescription Drugs Advisory Committee / Division of Pulmonary / Allergy / and Rheumatology Products To / OTC Advisory Panel / Review Division / Nonprescription Drugs Advisory Committee / Advisory Committee / / Person Fathia Gibril / Sally Seymour / / Position physician / Commissioner / Deputy Director for Safety / / Product Primatene Mist / epinephrine / medication / OTC drug / / PublishedMedium the OTC Drug Review / The OTC Advisory Panel review / the OTC review / / RadioStation TFM / / Technology alpha / / URL http /
SocialTag |
FDA Briefing Document Nonprescription Drugs Advisory Committee Meeting February 26, 2014 The committee will discuss whether over-the-counter bronchodilators administered by hand-held rubber bulb nebulizers for the tempor